Immunotherapy Has Big Potential In Ovarian Cancer Treatment
November 27, 2017 8:50 pmEarly studies are showing promise for immunotherapy agents such as checkpoint inhibitors in the treatment field of ovarian cancer, according to Jonathan Ledermann, M.D.
One such study is JAVELIN Ovarian 200, a study of Bavencio (avelumab) alone or in combination … Read more